HALO logo
halo search icon
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc.
MDGL · NAS

Madrigal Pharmaceuticals, Inc.

US$513.47

Price Arrow1.65 (0.322%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO All
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Madrigal Pharmaceuticals, Inc. Overview

MDGL Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Weak

About MDGL

icon

Telephone

1.267.824.2827

icon

Address

Suite 200, 200 Barr Harbor Drive, Four Tower Bridge, West Conshohocken, PA 19428

Description

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

MDGL Price Chart

Key Stats

Market Cap

US$11.80B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 265 - 615

Trade Value (12mth)

US$38,557,306.00

1 week

-2.27%

1 month

-3.01%

YTD

-13.82%

1 year

84.61%

All time high

615.00

Key Fundamentals

EPS 3 yr Growth

-25.40%

EBITDA Margin

-31.20%

Operating Cashflow

-$190m

Free Cash Flow Return

-20.80%

ROIC

-31.60%

Interest Coverage

-13.40

Quick Ratio

3.80

Other Data

Shares Outstanding (Fully Diluted)

29m

HALO Sector

Healthcare

Next Company Report Date

25-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

MDGL Announcements

Latest Announcements

DateAnnouncements
06 May 26
06 May 26
06 May 26
06 May 26
29 April 26

MDGL Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-19.99-21.9-12.85locklocklock
EPS (Fully Diluted)
$locklocklocklock-19.99-21.9-12.85locklocklock
Growth
%locklocklocklock-16-9.541.3locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Madrigal Pharmaceuticals, Inc. (MDGL:NAS)?
Halo FAQ
The current share price of Madrigal Pharmaceuticals, Inc. (MDGL:NAS) is USD$513.47.
What is the 52-week high share price for Madrigal Pharmaceuticals, Inc. (MDGL:NAS)?
Halo FAQ
The 52-week high share price for Madrigal Pharmaceuticals, Inc. (MDGL:NAS) is USD$615.00.
What is the 52-week low share price for Madrigal Pharmaceuticals, Inc. (MDGL:NAS)?
Halo FAQ
The 52-week low share price for Madrigal Pharmaceuticals, Inc. (MDGL:NAS) is USD$265.00.
What is the dividend yield for Madrigal Pharmaceuticals, Inc. (MDGL:NAS)?
Halo FAQ
Madrigal Pharmaceuticals, Inc. (MDGL:NAS) does not pay a dividend.
What was Madrigal Pharmaceuticals, Inc. (MDGL:NAS) last dividend payment?
Halo FAQ
Madrigal Pharmaceuticals, Inc. (MDGL:NAS) does not pay a dividend.
What is the franking level for Madrigal Pharmaceuticals, Inc. (MDGL:NAS)?
Halo FAQ
Madrigal Pharmaceuticals, Inc. (MDGL:NAS) has a franking level of 0.00%.
In which sector is Madrigal Pharmaceuticals, Inc. (MDGL:NAS) classified?
Halo FAQ
Madrigal Pharmaceuticals, Inc. (MDGL:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.